These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16808962)

  • 1. Ureteral obstruction after dextranomer/hyaluronic acid copolymer injection for treatment of secondary vesicoureteral reflux after renal transplantation.
    Seifert HH; Mazzola B; Zellweger T; Ruszat R; Muller A; Burkhalter F; Steiger J; Sulser T; Bachmann A
    Urology; 2006 Jul; 68(1):203.e17-9. PubMed ID: 16808962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral injection therapy with dextranomer/hyaluronic acid copolymer (Deflux) for treatment of secondary vesicoureteral reflux after renal transplantation.
    Seifert HH; Mazzola B; Ruszat R; Muller A; Steiger J; Bachmann A; Sulser T
    J Endourol; 2007 Nov; 21(11):1357-60. PubMed ID: 18042030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral reflux.
    Arlen AM; Pakalniskis BL; Cooper CS
    J Pediatr Urol; 2012 Jun; 8(3):e27-30. PubMed ID: 22209086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series.
    Rubenwolf PC; Ebert AK; Ruemmele P; Rösch WH
    Urology; 2013 Mar; 81(3):659-62. PubMed ID: 23452811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
    Stenberg A; Larsson E; Läckgren G
    J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer.
    Nseyo U; Mancini JG; Wiener JS
    Urology; 2013 Jan; 81(1):184-7. PubMed ID: 23200968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Obstruction With Asymptomatic Loss of Renal Function After Dextranomer/Hyaluronic Acid Copolymer (Deflux) Injection for Vesicoureteral Reflux: A Close Look at a Disturbing Outcome.
    Papagiannopoulos D; Rosoklija I; Cheng E; Yerkes E
    Urology; 2017 Mar; 101():63-66. PubMed ID: 27687330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
    Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
    J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R; Vandersteen D
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
    Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
    J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (deflux) injection for treatment of vesicoureteral reflux in children: a case series.
    Canning DA
    J Urol; 2014 May; 191(5):1409. PubMed ID: 24745538
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed onset ureteral obstruction following Deflux® injection for vesicoureteral reflux.
    Zemple RP; Potretzke AM; Kryger JV
    J Pediatr Urol; 2012 Jun; 8(3):e23-6. PubMed ID: 22257585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM; Peele PB; Docimo SG
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.
    Sheth KR; White JT; Stanasel I; Janzen N; Mittal A; Koh CJ; Austin PF; Roth DR; Tu DD; Gonzales ET; Ryan S; Jorgez C; Seth A
    J Pediatr Urol; 2018 Dec; 14(6):554.e1-554.e6. PubMed ID: 30146426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children.
    Cerwinka WH; Qian J; Easley KA; Scherz HC; Kirsch AJ
    J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late ureteral obstruction after injection of dextranomer/hyaluronic acid copolymer.
    Christen S; Mendoza M; Gobet R; Bode P; Weber D
    Urology; 2014 Apr; 83(4):920-2. PubMed ID: 24411212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates.
    Bar-Yosef Y; Castellan M; Joshi D; Labbie A; Gosalbez R
    J Urol; 2011 Jun; 185(6 Suppl):2531-4. PubMed ID: 21555029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.
    Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM
    J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distal and late ureteral obstruction: a rare complication following dextranomer/hyaluronic acid injection for vesicoureteral reflux in children].
    Abbo O; Bouali O; Beauval JB; Moscovici J; Galinier P
    Prog Urol; 2012 Mar; 22(3):192-4. PubMed ID: 22364632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.